01
Cash & equivalents increased 13.8%
Cash & equivalents changed +13.8% from the comparable as-filed period.
$42.6M→$48.5MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTFulcrum Therapeutics, Inc.'s latest supported as-filed period reports interest income of $3.1M. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +13.8% from the comparable as-filed period.
Net income changed -51.4% from the comparable as-filed period.
Operating income changed -47.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
FULC · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-353278SEC ↗8-KAug 10, 2026Period Aug 7, 20260001193125-26-341385SEC ↗10-QJul 30, 2026Period Jun 30, 20260001193125-26-326098SEC ↗4Jul 20, 2026Period Jul 16, 20260001178579-26-000016SEC ↗4Jul 15, 2026Period Jul 13, 20260001178579-26-000014SEC ↗4Jul 2, 2026Period Jun 30, 20260001193125-26-294703SEC ↗4Jul 2, 2026Period Jun 30, 20260001193125-26-294699SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed -4.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed +13.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-294697